• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Inconsistent Safety Outcome Reporting in Randomized Clinical Trials of COVID-19 Vaccines Complicates Informed Medical Decisions.新冠疫苗随机临床试验中安全结果报告不一致，使明智的医疗决策变得复杂。
Drug Saf. 2021 Nov;44(11):1121-1123. doi: 10.1007/s40264-021-01108-5. Epub 2021 Aug 17.
2
The CONSORT Framework.CONSORT框架。
JAMA Surg. 2021 Sep 1;156(9):877-878. doi: 10.1001/jamasurg.2021.0549.
3
Transparent reporting of trials is essential.透明报告试验至关重要。
Am J Gastroenterol. 2013 Aug;108(8):1231-5. doi: 10.1038/ajg.2012.457.
4
Editorial: Reporting Clinical Trials with Important Modifications Due to Extenuating Circumstances, Including the COVID-19 Pandemic: CONSERVE 2021.社论：报告因特殊情况（包括 COVID-19 大流行）而进行重要修改的临床试验：CONSERVE 2021。
Med Sci Monit. 2021 Aug 30;27:e934514. doi: 10.12659/MSM.934514.
5
Reporting in randomized trials published in International Journal of Cardiology in 2011 compared to the recommendations made in CONSORT 2010.2011年发表在《国际心脏病学杂志》上的随机试验报告与CONSORT 2010中的建议进行了比较。
Int J Cardiol. 2012 Oct 18;160(3):208-10. doi: 10.1016/j.ijcard.2012.06.045. Epub 2012 Jun 25.
6
Poor reporting may infer poor science: lessons learned from asthma trials.报告不佳可能暗示科学水平欠佳：从哮喘试验中吸取的教训
Prim Care Respir J. 2013 Dec;22(4):388-90. doi: 10.4104/pcrj.2013.00095.
7
Current Evidence From the Randomized Controlled Trials Rehabilitation Checklist (RCTRACK) reporting guideline project.来自随机对照试验康复检查表（RCTRACK）报告指南项目的当前证据。
Arch Phys Med Rehabil. 2021 Aug;102(8):1665-1667. doi: 10.1016/j.apmr.2021.04.008. Epub 2021 May 12.
8
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.《CONSORT 2010声明：报告平行组随机试验的更新指南》
Int J Surg. 2011;9(8):672-7. doi: 10.1016/j.ijsu.2011.09.004. Epub 2011 Oct 13.
9
Consolidated Standards of Reporting Trials (CONSORT) extensions covered most types of randomized controlled trials, but the potential workload for authors was high.CONSORT 扩展标准涵盖了大多数类型的随机对照试验，但作者的潜在工作量很大。
J Clin Epidemiol. 2019 Sep;113:168-175. doi: 10.1016/j.jclinepi.2019.05.030. Epub 2019 May 30.
10
Reply to the Hong-Lin Chen article on CONSORT (2010) recommendations.对陈宏林关于CONSORT（2010）建议的文章的回复。
Int J Cardiol. 2012 Dec 15;162(1):4-5. doi: 10.1016/j.ijcard.2012.10.017. Epub 2012 Nov 6.

引用本文的文献

1
Health Care Workers' Sick Leave due to COVID-19 Vaccination in Context With SARS-CoV-2 Infection and Quarantine-A Multicenter Cross-Sectional Survey.与严重急性呼吸综合征冠状病毒2感染和隔离相关的医护人员因接种新冠病毒疫苗而请病假的情况——一项多中心横断面调查
Open Forum Infect Dis. 2022 Apr 14;9(7):ofac203. doi: 10.1093/ofid/ofac203. eCollection 2022 Jul.
2
Self-Reported adverse events among Chinese healthcare workers immunized with COVID-19 vaccines composed of inactivated SARS-CoV-2.接种 SARS-CoV-2 灭活疫苗的中国医护人员自我报告的不良反应。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2064134. doi: 10.1080/21645515.2022.2064134. Epub 2022 Apr 22.

本文引用的文献

1
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.一种灭活严重急性呼吸综合征冠状病毒2疫苗（科兴新冠疫苗）在60岁及以上健康成年人中的安全性、耐受性和免疫原性：一项随机、双盲、安慰剂对照的1/2期临床试验
Lancet Infect Dis. 2021 Jun;21(6):803-812. doi: 10.1016/S1473-3099(20)30987-7. Epub 2021 Feb 3.
2
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
3
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.在年轻和老年成年人中进行的一次单盲、随机、对照、2/3 期试验中，观察 ChAdOx1 nCoV-19 疫苗在初免-加强免疫方案中的安全性和免疫原性（COV002）。
Lancet. 2021 Dec 19;396(10267):1979-1993. doi: 10.1016/S0140-6736(20)32466-1. Epub 2020 Nov 19.
4
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.一项在 18-59 岁健康成年人中进行的新型冠状病毒灭活疫苗的安全性、耐受性和免疫原性的随机、双盲、安慰剂对照、1/2 期临床试验。
Lancet Infect Dis. 2021 Feb;21(2):181-192. doi: 10.1016/S1473-3099(20)30843-4. Epub 2020 Nov 17.
5
The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).布莱顿协作组织：满足免疫接种后不良事件（AEFI）标准化病例定义的需求。
Vaccine. 2002 Dec 13;21(3-4):298-302. doi: 10.1016/s0264-410x(02)00449-8.

Inconsistent Safety Outcome Reporting in Randomized Clinical Trials of COVID-19 Vaccines Complicates Informed Medical Decisions.

作者信息

Blais Joseph E, Wei Yue, Chui Celine S L, Chan Esther W, Wong Ian C K

机构信息

Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, General Office, L02-56 2/F Laboratory Block, 21 Sassoon Road, Pokfulam, Hong Kong SAR, China.

School of Nursing, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.

出版信息

Drug Saf. 2021 Nov;44(11):1121-1123. doi: 10.1007/s40264-021-01108-5. Epub 2021 Aug 17.

DOI:10.1007/s40264-021-01108-5
PMID:34405364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8370447/
Abstract
摘要